Home
Statistics
Acknowledgment
Enquire
Keyword Search
Complex Search
Segment Search
Peptide Mapping
Browse On
Mode of delivery
Animal model
Origin/Source
Peptide Length
Similarity
BLAST Search
Smith-Waterman
General
Help or Guide
Data Submission
Curators
Developers
Contact Us
Browse result page of B3Pdb
The total number entries retrieved from this search are
235
, scroll left/right for detailed information.
B3pdbID
PEPTIDE NAME
PEPTIDE SEQUENCE (1-letter)
PEPTIDE SEQUENCE (3-letter)
N-TERMINAL MODIFICATION
C-TERMINAL MODIFICATION
CHEMICAL MODIFICATION
PEPTIDE LENGTH
PEPTIDE CONFORMATION
PEPTIDE NATURE
SOURCE/ORIGIN OF PEPTIDE
SMILES
CELL LINE
In vitro
CONCENTRATION
In vitro
METHOD
In vitro
RESULT
ANIMAL MODEL
In vivo
CONCENTRATION
In vivo
MODE OF DELIVERY
In vivo
METHOD
In vivo
RESULT
ACTION
TRANSPORT TYPE
SUBCELLULAR LOCALISATION
COMBINATION
PHYSICAL CONDITION
RESPONSE
RESULT
LABEL
PMID
b3pdb_0760
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, serum
200 min
Direct iodination
20347901
b3pdb_0761
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
HPLC
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
half life, brain
900 min
Direct iodination
20347901
b3pdb_0762
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.00024 mL/(g x min)
Direct iodination
20347901
b3pdb_0763
CTOP
fCYwOrnTPenT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Orn-Thr-Pen-Thr-NH2
NA
NA
Cys2-Pen7
8
Linear
NA
Chemically synthesized
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2(C)C)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCN)C(O)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Initial disrobution volume
0.01894 ml/g
Direct iodination
20347901
b3pdb_0764
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
10.29%
Direct iodination
20347901
b3pdb_0765
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
89.71%
Direct iodination
20347901
b3pdb_0766
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
Antinociception
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
ICV/SC ratio
0.0000114
NA
9723966
b3pdb_0767
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.00218 mL/(g x min)
Direct iodination
20347901
b3pdb_0768
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Initial disrobution volume
0.02148 ml/g
Direct iodination
20347901
b3pdb_0769
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.01398 ml/g
Direct iodination
26465925
b3pdb_0770
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00063 mL/(g x min)
Direct iodination
26465925
b3pdb_0771
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00019 mL/(g x min)
Direct iodination
24164260
b3pdb_0772
Dermorphin
YaFGYPS-NH2
Tyr-(D)Ala-Phe-Gly-Tyr-Pro-Ser-NH2
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(NC(C(=O)N)CO)C4N(C(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00035 mL/(g x min)
Direct iodination
8041755
b3pdb_0824
RC-121
fCYwKVCT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
mouse,rat
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
half life, brain
14.4 min
Direct iodination
1975697
b3pdb_0825
RC-121
fCYwKVCT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
mouse,rat
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.05 min-1
Direct iodination
1975697
b3pdb_0826
RC-121
fCYwKVCT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
mouse,rat
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.0000401 mL/(g x min)
Direct iodination
1975697
b3pdb_0827
RC-121
fCYwKVCT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
mouse,rat
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0136 ml/g
Direct iodination
1975697
b3pdb_0828
RC-121
fCYwKVCT-NH2
(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
mouse,rat
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(N)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
half life, serum
4.6 min
Direct iodination
1975697
b3pdb_0829
RC-161
Ac-fCYwKVCT-NH2
Ac-(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
human
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
half life, brain
53 min
Direct iodination
1975697
b3pdb_0830
RC-161
Ac-fCYwKVCT-NH2
Ac-(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
human
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.01 min-1
Direct iodination
1975697
b3pdb_0831
RC-161
Ac-fCYwKVCT-NH2
Ac-(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
human
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
non saturable
NA
NA
NA
Unidirectional influx rate constant
0.000232 mL/(g x min)
Direct iodination
1975697
b3pdb_0832
RC-161
Ac-fCYwKVCT-NH2
Ac-(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
human
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0164 ml/g
Direct iodination
1975697
b3pdb_0833
RC-161
Ac-fCYwKVCT-NH2
Ac-(D)Phe-Cys-Tyr-(D)Trp-Lys-Val-Cys-Thr-NH2
NA
NA
Cys2-Cys7
8
Linear
NA
human
O=C(N)C(NC(=O)C2NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C)Cc1ccccc1)CSSC2)Cc3ccc(O)cc3)Cc5c4ccccc4nc5)CCCCN)C(C)C)C(O)C
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
half life, serum
1.7 min
Direct iodination
1975697
b3pdb_0834
[Lys7] Dermorphin
YaFGYPK
Tyr-D-Ala-Phe-Gly-Tyr-Pro-Lys
NA
NA
NA
7
Linear
NA
Chemically synthesized
O=C(N[C@@H](C(=O)O)CCCCN)[C@H]4N(C(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C)Cc2ccccc2)Cc3ccc(O)cc3)CCC4
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
b3pdb_0856
E-2078
(NMe)YGGFLR(NMe)Rl-NHC2H5
(NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-(D)Leu-NHC2H5
NA
NA
NA
8
Linear
NA
NA
CCNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N(C)C(=O)[C@H](CCCN=C(N)N) NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H] (CC2=CC=C(C=C2)O)NCNA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
14.41%
Direct iodination
1681528
b3pdb_0857
E-2078
(NMe)YGGFLR(NMe)Rl-NHC2H5
(NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-(D)Leu-NHC2H5
NA
NA
NA
8
Linear
NA
NA
CCNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N(C)C(=O)[C@H](CCCN=C(N)N) NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H] (CC2=CC=C(C=C2)O)NCNA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
85.59%
Direct iodination
1681528
b3pdb_0858
E-2078
(NMe)YGGFLR(NMe)Rl-NHC2H5
(NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-(D)Leu-NHC2H5
NA
NA
NA
8
Linear
NA
NA
CCNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N(C)C(=O)[C@H](CCCN=C(N)N) NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H] (CC2=CC=C(C=C2)O)NCNA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(brain/perfusate)
0.00254 ml/g
Direct iodination
1681528
b3pdb_0859
E-2078
(NMe)YGGFLR(NMe)Rl-NHC2H5
(NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-(D)Leu-NHC2H5
NA
NA
NA
8
Linear
NA
NA
CCNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N(C)C(=O)[C@H](CCCN=C(N)N) NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H] (CC2=CC=C(C=C2)O)NCNA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(capillary/perfusate)
0.000367 ml/g
Direct iodination
1681528
b3pdb_0860
E-2078
(NMe)YGGFLR(NMe)Rl-NHC2H5
(NMe)Tyr-Gly-Gly-Phe-Leu-Arg-(NMe)Arg-(D)Leu-NHC2H5
NA
NA
NA
8
Linear
NA
NA
CCNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)N(C)C(=O)[C@H](CCCN=C(N)N) NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H] (CC2=CC=C(C=C2)O)NCNA
NA
NA
Capillary deplition in situ b p
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
CD(parenchyma/perfusate)
0.00218 ml/g
Direct iodination
1681528
b3pdb_0865
cationic AVP4-9
Pyr-N(CPHR)CPRG-NH2
Pyr-Asn-(Cys-Pro-His-Arg)-Cys-Pro-Arg-Gly-NH2
NA
NA
Cys3A-Cys3B
10
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Capillary depletion (capillary/serum)
0.0186 ml/g
Direct iodination
10411563
b3pdb_0866
cationic AVP4-9
Pyr-N(CPHR)CPRG-NH2
Pyr-Asn-(Cys-Pro-His-Arg)-Cys-Pro-Arg-Gly-NH2
NA
NA
Cys3A-Cys3B
10
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Capillary depletion (parenchyma/serum)
0.406 ml/g
Direct iodination
10411563
b3pdb_0867
cationic AVP4-9
Pyr-N(CPHR)CPRG-NH2
Pyr-Asn-(Cys-Pro-His-Arg)-Cys-Pro-Arg-Gly-NH2
NA
NA
Cys3A-Cys3B
10
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
4.38%
Direct iodination
10411563
b3pdb_0868
cationic AVP4-9
Pyr-N(CPHR)CPRG-NH2
Pyr-Asn-(Cys-Pro-His-Arg)-Cys-Pro-Arg-Gly-NH2
NA
NA
Cys3A-Cys3B
10
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
95.62%
Direct iodination
10411563
b3pdb_0869
cationic AVP4-9
Pyr-N(CPHR)CPRG-NH2
Pyr-Asn-(Cys-Pro-His-Arg)-Cys-Pro-Arg-Gly-NH2
NA
NA
Cys3A-Cys3B
10
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
saturable
NA
NA
NA
Unidirectional influx rate constant
0.00031 mL/(g x min)
Direct iodination
10411563
b3pdb_0972
Doxorubicin-SynB3
Doxorubicin-linker-RRLSYSRRRF
Doxorubicin-linker-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe
NA
NA
NA
10
Linear
NA
NA
NA
NA
NA
NA
NA
NA
In situ perfusion (single time)
NA
NA
NA
Permeability
NA
NA
NA
Unidirectonal influx rate constant
0.1386 mL/(g x min)
H3/C14
10727512
b3pdb_0973
Doxorubicin-(D)-SynB
Doxorubicin-linker-rrlsysrrrf
Doxorubicin-linker-(D)Arg-(D)Arg-(D)Leu-(D)Ser-(D)Tyr-(D)Ser-(D)Arg-(D)Arg-(D)Arg-(D)Phe
NA
10
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.9618 ml/g
H3/C14
11123372
b3pdb_0974
SynB3
RRLSYSRRRF-NH2
Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe-NH2
NA
10
Linear
NA
Chemically synthesized
NA
NA
NA
NA
NA
NA
NA
in situ brain perfusion
NA
NA
NA
Permeability
NA
NA
NA
Volume of donor compartment
0.7884 ml/g
H3/C14
11123372
b3pdb_0995
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
Brain elemination rate constant
0.0178 min-1
Direct iodination
3440215
b3pdb_0996
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
Efflux study ICU
NA
NA
NA
NA
NA
NA
NA
Permeability
NA
NA
NA
half life, brain
17.6 min
Direct iodination
3440215
b3pdb_0997
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
Shake Flask
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
Log P
0.00176
Direct iodination
3440215
b3pdb_0998
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00113 mL/(g x min)
Direct iodination
3440215
b3pdb_0999
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0226 ml/g
Direct iodination
3440215
b3pdb_1000
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0025 mL/(g x min)
Direct iodination
3440215
b3pdb_1001
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0177 ml/g
Direct iodination
3440215
b3pdb_1002
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.00292 mL/(g x min)
Direct iodination
3440215
b3pdb_1003
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0199 ml/g
Direct iodination
3440215
b3pdb_1004
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Unidirectional influx rate constant
0.0025 mL/(g x min)
Direct iodination
3440215
b3pdb_1005
D-[Ala1]-peptide T-a
aSTTTNYT-NH2
(D)Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2
NA
NA
NA
8
Linear
NA
Chemically synthesized
C[C@H]([C@@H](C(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)O
NA
NA
NA
NA
NA
NA
Intravenous
NA
NA
NA
Permeability
NA
NA
NA
Initial disrobution volume
0.0227 ml/g
Direct iodination
3440215
b3pdb_1006
NT1, Neurotensin8-13
(NαMe)RK-(3,4-dehydro)PWtLL
(NαMe)Arg-Lys-(3,4-dehydro)Pro-Trp-tLeu-Leu
NA
NA
NA
6
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% parenchyma
83%
H3/C14
8574648
b3pdb_1007
NT1, Neurotensin8-13
(NαMe)RK-(3,4-dehydro)PWtLL
(NαMe)Arg-Lys-(3,4-dehydro)Pro-Trp-tLeu-Leu
NA
NA
NA
6
Linear
NA
Chemically synthesized
NA
NA
NA
Capillary depletion
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
% capillary
17%
H3/C14
8574648
previous
1
2
3
4
5
next
IIITD/CB
Raghava's Group
IMTECH
CellPPDMOD